The min-102 placebo is supplied as an oral suspension with similar appearance to min-102 drug product. min-102 placebo oral suspension is packaged in an amber glass bottle with filled volume based on the required clinical dose
MT-2-04
Phase 2 small_molecule active
Quick answer
The min-102 placebo is supplied as an oral suspension with similar appearance to min-102 drug product. min-102 placebo oral suspension is packaged in an amber glass bottle with filled volume based on the required clinical dose for Rett Syndrome is a Phase 2 program (small_molecule) at Minoryx Therapeutics S.L. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Minoryx Therapeutics S.L.
- Indication
- Rett Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active